Effect of SGLT2 inhibitors on anemia and their possible clinical implications Aleix Cases; Secundino Cigarrán; José Luis Górriz; Julio Nuñez;

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;

Information and consensus document for the detection and management of chronic kidney disease Rafael García-Maset; Jordi Bover; Julián Segura de la Morena; Marian Goicoechea Diezhandino; Jesús Cebollada del Hoyo; Javier Escalada San Martin; Lorenzo Fácila Rubio; Javier Gamarra Ortiz; Jose A. García-Donaire; Lisardo García-Matarín; Sílvia Gràcia Garcia; María Isabel Gutiérrez Pérez; Julio Hernández Moreno; Pilar Mazón Ramos; Rosario Montañés Bermudez; Manuel Muñoz Torres; Pedro de Pablos-Velasco; Manuel Pérez-Maraver; Carmen Suárez Fernández; Salvador Tranche Iparraguirre; José Luis Górriz;